We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.82 | 1.14% | 72.85 | 73.075 | 71.82 | 72.22 | 7,452,085 | 01:00:00 |
From May 2021 to May 2024
By Will Feuer
Boston Scientific Corp. said its first-quarter profit fell even as sales rose amid higher costs.
The Marlborough, Mass.-based medical-device maker posted net income of $110 million, compared with $341 million a year earlier. Per-share earnings were 7 cents, compared with 23 cents.
Stripping out one-time items, the company's adjusted earnings were 39 cents a share. Analysts surveyed by FactSet forecast adjusted earnings of 38 cents a share.
Sales rose 10% to $3.03 billion. Analysts had anticipated sales of $2.96 billion, according to FactSet. Cost of products sold rose from $894 million to $955 million.
Boston Scientific posted 9.1% sales growth in its medical-surgical division and 11.4% growth in cardiovascular sales.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
April 27, 2022 06:58 ET (10:58 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
